CEN BIOTECH INC Annual Operating Income (Loss) in USD from 2014 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cen Biotech Inc quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2021.
  • Cen Biotech Inc Operating Income (Loss) for the quarter ending September 30, 2022 was -$486K, a 24.6% increase year-over-year.
  • Cen Biotech Inc Operating Income (Loss) for the twelve months ending September 30, 2022 was -$2.71M, a 84.6% increase year-over-year.
  • Cen Biotech Inc annual Operating Income (Loss) for 2021 was -$19M, a 648% decline from 2020.
  • Cen Biotech Inc annual Operating Income (Loss) for 2020 was -$2.54M, a 1.4% increase from 2019.
  • Cen Biotech Inc annual Operating Income (Loss) for 2019 was -$2.58M, a 41% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$19M -$16.5M -648% Jan 1, 2021 Dec 31, 2021 10-K 2022-04-14
2020 -$2.54M +$36.1K +1.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-14
2019 -$2.58M +$1.79M +41% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$4.37M +$7.24M +62.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-14
2017 -$11.6M -$5.02M -76.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-16
2016 -$6.59M -$5.55M -531% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-16
2015 -$1.04M +$1.97M +65.3% Jan 1, 2015 Dec 31, 2015 10-K 2017-04-13
2014 -$3.01M Jan 1, 2014 Dec 31, 2014 10-K/A 2016-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.